Replies to post #71409 on Biotech Values

[ghmm]

Targanta shareholders may also be entitled to receive additional contingent cash payments upon the achievement of specified regulatory and commercial milestones $2/sh and there are contingencies potentially worth $within agreed upon time periods:

Do you know how this works in practice? Will it be holds as of the closing data of the transaction and then will they have to maintain some list of the shareholders or get it from brokers?

Its not like Oritavancin was a complete flop if the stock trades to a discount to the $2 there could be a free call option on some descent milestone payments.